<< Back to Summary 
The USA House of Representatives Committee on Energy and Commerce and its Subcommittee on Oversight and Investigations are probing the “withholding of clinical trial data that may significantly affect the medical management of hypercholesterolemia, as well as the use of misleading statement in direct-to-consumer advertisements for prescription medicines.” Do you believe that Vytorin direct to consumer ads have been misleading?
#Response DateOther (please specify)
1.1/30/2008 11:45:00 PMno data on Zetia efficacy
2.1/31/2008 8:50:00 PMnot sure
3.1/31/2008 8:53:00 PMnot sure
4.1/31/2008 9:52:00 PMI have not seen these ads